| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.009 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.009 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |